Biotech Analysts Bauser and Walsh, along wit Dr. Christopher Merrick, discuss treatment options for bronchiectasis, including Electromed’s (ELMD) and Insmed’s (INSM) recently launched BRINSUPRI (brensocatib) on an Analyst/Industry conference call to be held on February 18 at 2 pm. Webcast Link
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELMD: